Atlas Trials

Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer

Clinical trial NCT00003733 · UNKNOWN

Trial details

NCT number
NCT00003733
Sponsor
SmithKline Beecham
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
1997-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.